Owners, management and financials
CVR: 45469964
Secondary names: Imprint Biomedicine ApS, Imprint Bio ApS, Imprint Therapeutics ApS
DKK -925,659
Gross profit
Net result: DKK -1,962,610
Ahn Capital ApS (33,33-49,99%), ECF Holding ApS (33,33-49,99%)
1 more
CVR · view owners
Emil Christian Fischer, Faizaan Mohammad
1 more in management
CVR · view management
Active
Founded 6 March 2025
CVR · view overview
3 employees
Annual report 2026 · average
Name registered: Imprint Medicine ApS
CVR · 06/03/2025
View the full event history
Imprint Medicine ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2025. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Emil Christian Fischer, Faizaan Mohammad and Peter Ahn Mouritzen. The company is owned by Ahn Capital ApS, ECF Holding ApS and Shams ApS. According to the 2026 annual report, the company had an average of 3 employees. In 2026, the company reported a gross profit of DKK -925,659 and a net result of DKK -1,962,610. Equity in the 2026 report amounted to DKK -1,941,610.
Selskabets formål er at udføre aktiviteter relaterede til forskning og udvikling rettet mod bioteknologi, og udvikling og kommercialisering af lægemidler, samt andre lægemiddel-udvikling relaterede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202606/03/2025 – 31/03/2026 | -926 t. | -2 mio. | 2.5 mio. | -1.9 mio. | 3 |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Imprint Medicine ApS is 45469964.
Imprint Medicine ApS is owned by Ahn Capital ApS, ECF Holding ApS and Shams ApS.
The management of Imprint Medicine ApS consists of Emil Christian Fischer, Faizaan Mohammad and Peter Ahn Mouritzen.
In 2026, Imprint Medicine ApS reported a gross profit of DKK -925,659.
Imprint Medicine ApS had an average of 3 employees in the 2026 financial year according to the annual report.
Imprint Medicine ApS was founded on 6 March 2025.
Claim this page to add your logo and social links. Free to get started.
Imprint Medicine ApS has published its annual report for 2026. Gross profit came to DKK -925,659, and the net result was DKK -1,962,610.
As of May 27, 2026, Cedra Godkendt Revisionsaktieselskab has been appointed auditor of Imprint Medicine ApS.
As of March 6, 2025, Peter Ahn Mouritzen is registered as director of Imprint Medicine ApS.
As of March 6, 2025, Emil Christian Fischer is registered as director of Imprint Medicine ApS.
As of March 6, 2025, Faizaan Mohammad is registered as director of Imprint Medicine ApS.
As of March 6, 2025, Ahn Capital ApS is registered as an owner of Imprint Medicine ApS with an ownership share of 33%.
As of March 6, 2025, ECF Holding ApS is registered as an owner of Imprint Medicine ApS with an ownership share of 33%.
As of March 6, 2025, Shams ApS is registered as an owner of Imprint Medicine ApS with an ownership share of 33%.
Imprint Medicine ApS was founded on March 6, 2025.
Companies in the same industry and area
CVR 45436497
CVR 46543912
CVR 44478587
CVR 31427169
CVR 43506242
